Ang, J. E., Pal, A., Asad, Y. J., Henley, A. T., Valenti, M., Box, G., . . . Raynaud, F. (2017). Modulation of plasma metabolite biomarkers of MAPK pathway with the MEK inhibitor RO4987655: Pharmacodynamic and predictive potential in metastatic melanoma. Mol Cancer Ther.
Chicago ZitierstilAng, Joo Ern, et al. "Modulation of Plasma Metabolite Biomarkers of MAPK Pathway With the MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma." Mol Cancer Ther 2017.
MLA ZitierstilAng, Joo Ern, et al. "Modulation of Plasma Metabolite Biomarkers of MAPK Pathway With the MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma." Mol Cancer Ther 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.